22157.jpg
Myasthenia Gravis (MG) Market Analysis & Forecast to 2032: Global Opportunity Assessment, Epidemiology, Clinical Trials, Unmet Needs, Key Players
January 24, 2024 03:43 ET | Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "Myasthenia Gravis Market Opportunity Assessment, Epidemiology, Clinical Trials, Unmet Needs and Forecast to 2032" report has been added to ...
Global Myasthenia Gravis Treatment Market
Global Myasthenia Gravis Treatment Market Forecast and Trends 2023-2028, Featuring Profiles of AbbVie, Bausch Health, Gilead Sciences, Merck, Servier and Teva
December 18, 2023 06:43 ET | Research and Markets
Dublin, Dec. 18, 2023 (GLOBE NEWSWIRE) -- The "Global Myasthenia Gravis Treatment Market: Forecast and Trends" report has been added to ResearchAndMarkets.com's offering. The global market for...
Logo.png
Myasthenia Gravis Market is Projected to Boost at a Moderate Growth Rate by 2032, Estimates DelveInsight | Leading Companies - DAS-MG, Catalyst, Cabaletta Bio, Janssen, Argenx, UCB Pharma, Alexion, Immunovant
October 25, 2023 13:00 ET | DelveInsight Business Research LLP
New York, USA, Oct. 25, 2023 (GLOBE NEWSWIRE) -- Myasthenia Gravis Market is Projected to Boost at a Moderate Growth Rate by 2032, Estimates DelveInsight | Leading Companies - DAS-MG, Catalyst,...
AMR Logo.png
Myasthenia Gravis Treatment Market to Reach $3.1 Billion, Globally, by 2032 at 6.5% CAGR: Allied Market Research
May 15, 2023 21:00 ET | Allied Market Research
Portland, OR, May 15, 2023 (GLOBE NEWSWIRE) -- Allied Market Research published a report, titled, "Myasthenia Gravis Treatment Market by Drug class (Monoclonal antibodies, Intravenous...
22157.jpg
Outlook on the Myasthenia Gravis Diagnosis and Treatment Global Market to 2028 - Featuring Avadel Pharmaceuticals, Bausch Health Companies, Baxter International and CSL Behring Among Others
January 05, 2023 06:58 ET | Research and Markets
Dublin, Jan. 05, 2023 (GLOBE NEWSWIRE) -- The "Global Myasthenia Gravis Diagnosis and Treatment Market Forecast, 2022-2028" report has been added to ResearchAndMarkets.com's offering. The global...
MicrosoftTeams-image (5).png
Myasthenia Gravis Market to Reach US$ 2.4 Bn by 2027, TMR Report
July 28, 2022 13:30 ET | Transparency Market Research
Wilmington, Delaware, United States, July 28, 2022 (GLOBE NEWSWIRE) -- Transparency Market Research Inc.: Analysts at TMR estimate the myasthenia gravis market to clip a CAGR of 8% during the...
Zion Market Research.jpg
Global Myasthenia Gravis Market Will Reach USD 2,091 Million By 2025: Zion Market Research
March 19, 2019 09:07 ET | Zion Market Research
New York, NY, March 19, 2019 (GLOBE NEWSWIRE) -- Zion Market Research has published a new report titled “Myasthenia Gravis Market by Diagnosis (Edrophonium Tests, Blood Tests, Pulmonary Function...
Transparency Market Research.jpg
Myasthenia Gravis Market to become worth US$2,313.1 mn by 2025, Says TMR
June 18, 2018 05:53 ET | Transparency Market Research
Albany, NY, June 18, 2018 (GLOBE NEWSWIRE) -- According to a research report by Transparency Market Research (TMR), the global myasthenia gravis market is expected to expand at a steady CAGR of...